RENEO PHARMACEUTICALS
Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases. It focuses on the development of treatments for genetic disorders associated with defects in energy metabolism resulting in myopathy that enable caregivers to improve the daily function and quality of life of patients suffering from these diseases by improving how their mitochondria work, preserving muscle function and preventing muscle injury, weakness, and wasting. The company was founded in 2014 and is headquartered in San Diego, California.
RENEO PHARMACEUTICALS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2014-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.reneopharma.com
Total Employee:
11+
Status:
Active
Contact:
+1 858-283-0280
Total Funding:
145 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Pappas Capital
Pappas Capital investment in Series B - Reneo Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series B - Reneo Pharmaceuticals
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series B - Reneo Pharmaceuticals
Abingworth
Abingworth investment in Series B - Reneo Pharmaceuticals
Amzak Health Investors
Amzak Health Investors investment in Series B - Reneo Pharmaceuticals
Chiesi Ventures
Chiesi Ventures investment in Series B - Reneo Pharmaceuticals
RiverVest
RiverVest investment in Series B - Reneo Pharmaceuticals
Rock Springs Capital
Rock Springs Capital investment in Series B - Reneo Pharmaceuticals
Aisling Capital
Aisling Capital investment in Series B - Reneo Pharmaceuticals
Novo Ventures
Novo Ventures investment in Series B - Reneo Pharmaceuticals
Key Employee Changes
Date | New article |
---|---|
2021-10-11 | Reneo Pharmaceuticals Appoints Ashley Hall as Chief Development Officer |
Official Site Inspections
http://www.reneopharma.com Semrush global rank: 2.4 M Semrush visits lastest month: 7.62 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago